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Abstract
Background: Endothelial progenitor cells (EPCs) have shown great potential in angiogenesis either by their
differentiation into endothelial cells or by secretion of angiogenic factors. Interferon-inducible protein 204 (Ifi204) has
been reported to participate in the regulation of cell growth and differentiation. However, its role in differentiation of
EPCs remains unknown. We proposed that Ifi204 could modulate the differentiation and regenerative abilities of EPCs.
Methods: Ifi204-expressing lentivirus and Ifi204 siRNA were introduced into EPCs to overexpress and suppress the
expression of Ifi204. Using fluorescence-activated cell sorting, immunocytochemistry, and quantitative PCR, endothelial
markers including CD31, VE-cadherin, and vWF were detected in the modified EPCs. An in-vitro incorporation assay and
a colony-forming assay were also performed.
Results: Evidence showed that Ifi204 inhibition decreased the endothelial differentiation and vasculogenic activities of
EPCs in vitro. In mice with hindlimb ischemia, downregulation of Ifi204 in EPCs, which was tracked by our newly
synthesized nanofluorogen, impaired neovascularization, with a corresponding reduction in hindlimb blood reperfusion
by postoperative day 14.
Conclusions: Ifi204 is required for EPC differentiation and neovascularization in vitro and in vivo. The regulatory roles of
Ifi204 in EPC differentiation may benefit the clinical therapy of ischemic vascular diseases.
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Background
In 1997, Asahara et al. [1] revolutionized the traditional
concept of postnatal neovascularization, proposing that
immature endothelial progenitor cells (EPCs) circulate
in the adult blood and participate in postnatal angiogenesis.
This idea was met with great enthusiasm because it sug-
gested that EPCs could be derived from peripheral blood
and used as a novel therapy in patients with vascular
disease, and thus was followed by booming research on
EPCs over the last decades. Upon ischemic stimuli, EPCs
are recruited to ischemic tissue and enhance angiogenesis
either by incorporation into neovascularization [2–5] or
by secreting angiogenic and cytoprotective cytokines
and growth factors [6–10]. To optimize therapeutic out-
comes, researchers have developed techniques such as
genetic modification of EPCs and so on [11–14].
Interferon-inducible protein 204 (Ifi204), a member of
the interferon-inducible p200 family of proteins, has par-
ticipated in the regulation of cell growth and differenti-
ation [15]. Evidence has shown that Ifi204 could promote
muscle cell differentiation by sequestering regulatory fac-
tors that block the differentiation process [16, 17]. Very
recently, our group reported that Ifi204 is downregulated
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in the bone marrow cells of diabetes mellitus type 2 mice
[18]. Because EPCs in diabetes mellitus have been re-
ported to be impaired in regenerative potency, we thus
proposed that Ifi204 could modulate the differentiation
and regenerative abilities of EPCs. Through overexpres-
sion and inhibition of Ifi204 in EPCs, we examined the
role of Ifi204 in EPC differentiation and vasculogenesis




All animal procedures were approved by the Ethic
Committee of Soochow University and carried out in
accordance with the Guidelines for the Care and Use of
Research Animals established by Soochow University.
C57/BL6 mice (8 weeks old, male) were housed at the
Animal Facility of Soochow University on a 12-hour
light/dark cycle with free access to water and standard
mouse food.
Isolation and identification of EPCs
Bone marrow cells were isolated from mouse bones as
described previously [19]. Briefly, cells were collected
from all bones smashed with a mortar and a pestle, and
were further isolated by density-gradient centrifugation
with Histopaque 1083 (Sigma, St. Louis, MO, USA).
Cells were cultured in Endothelial Cell Basal Medium-2
(Lonza, Basel, Switzerland), supplemented with EGM-2
MV SingleQuots (Lonza) and 10 % fetal bovine serum. All
the floating cells were washed out with fresh culture
medium 2 days after cell plating, and were further cul-
tured for 14 days before experiments. Then 5 μg/ml of
DiI-Ac-LDL solution (Biomedical Technologies Inc.,
Stoughton, MA, USA) was added to the cells and culture
continued for 4 hours. The cells were then fixed by 4 %
paraformaldehyde (PFA)/PBS and stained with DAPI
(Beyotime Biotechnology, Shanghai, China). Endocytosis
of Ac-LDL was observed under a fluorescent microscope
(Olympus, Tokyo, Japan).
Transfection of Ifi204 in EPCs
Mouse Ifi204 siRNAs were synthesized by GenePharma
Co. Ltd (Shanghai, China). The sequences for Ifi204 siRNAs
were designed as follows: sense (5′ to 3′), CCAACAAUGG
UUAUCUCAATT; and anti-sense (5′ to 3′), UUGAGA
UAACCAUUGUUGGTT. Cell transfection was performed
with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA),
according to the manufacturer’s protocols. Briefly, the cells
in 60 mm dishes were transfected with 200 pmol of Ifi204
siRNA and the scramble siRNA separately. Forty-eight
hours post transfection, the cells were harvested and the
efficiency of transfection was confirmed using reverse
transcription quantitative PCR (RT-qPCR). At the same
time, the transfected cells were further used in the in-
vitro assays.
Synthesis of lentivirus overexpressing Ifi204 and
transduction of lentivirus in EPCs
Ifi204 full-length CDS was cloned into the NotI/BamHI
sites of the LV5 vector (EF1A-GFP-PURO). Positive
clones of LV5-Ifi204 vectors were identified by DNA se-
quencing. Recombinant LV5 lentivirus containing Ifi204
gene was produced in the HEK 293 packaging cell line.
For infection, cells were exposed to viral supernatant at
a multiplicity of infection (MOI) of 50 for 24 hours. The
efficiency of transduction was estimated by calculating
the percentage of green fluorescence protein (GFP)-posi-
tive cells and RT-qPCR.
Fluorescence-activated cell sorting analysis
To detect endothelial lineage antigens on EPCs, fluores
cence-activated cell sorting (FACS) analysis was con-
ducted 4 days after siRNA transfection or lentivirus
transduction of EPCs. Surface expression of CD133 and
VE-cadherin was determined by phycoerythrin (PE)-con-
jugated antibody (e-Bioscience, San Diego, CA, USA)
against mouse CD133 and VE-cadherin. FITC-conjugated
anti-mouse PECAM (CD31) antibody (e-Bioscience) was
used to determine the surface expression of CD31. Isotype-
identical antibodies served as negative controls (BioLegend,
San Diego, CA, USA). The staining was performed for
20 minutes at 4 °C, followed by quantitative analysis with
MoFlo XDP (Beckman Coulter, Brea, CA, USA).
Immunocytochemistry
Attached cells were briefly fixed with ice-cold acetone
and blocked in antibody dilution buffer (2 % BSA/PBS)
for 1 hour at room temperature. After removal of the
blocking solution, primary antibodies anti-VE-cadherin
antibody (1:100; Santa Cruz, Dallas, TX, USA) and anti-
CD31 antibody (1:100; Santa Cruz) were added and cells
were incubated at 4 °C overnight. The cells were then
washed and incubated with Alexa 488 donkey anti-goat
IgG and Alexa 488 goat anti rabbit IgG (Invitrogen,
Carlsbad, CA, USA) for 30 minutes at room temperature.
Immunofluorescence was observed under a fluorescent
microscope (Olympus).
Real-time RT-PCR analysis
Cellular mRNA was extracted from each sample using
PureLink RNA Mini Kit (Ambion, Carlsbad, CA, USA)
according to the manufacturer’s instructions. cDNA was
synthesized using PrimeScript RT reagent Kit (TAKARA,
Tokyo, Japan). For qPCR, the converted cDNA samples
(2 μl) were amplified in a final volume of 10 μl using SYBR
Green Master Mix reagent (Applied Biosystems, Foster
City, CA, USA) and gene-specific primers with the
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StepOne Plus real-time PCR system (Applied Biosystems).
Sequences of the specific primers used in RT-PCR are pre-
sented in Table 1. The mean cycle threshold values were
used to calculate gene expression levels with normalization
to mouse GAPDH. Quantitative analyses were based on
three independent biological samples.
In-vitro vasculogenesis assay
Human umbilical cord-derived endothelial cells (HUVECs)
and EPCs with Ifi204 siRNA transfection or LV5-Ifi204
infection were used for tube formation assays as described
previously [19–21]. Fifty microliters of chilled Matrigel
matrix (BD, Bedford, MA, USA) was added into each well of
the 96-well plate and incubated at 37 °C for 30 minutes.
EPCs were labeled with DiI (Invitrogen, Eugene, OR, USA)
for 20 minutes. HUVECs together with DiI-labeled EPCs in
100 μl of 10 % FBS/EGM-2MV medium were added to each
well. The number of incorporated DiI-labeled cells into tubes
was counted under a fluorescent microscope (Olympus).
EPC colony-formation assay
EPCs with inhibition or overexpression of Ifi204 were cul-
tured in methylcellulose-based medium (MethoCultM3236;
Stem Cell Technologies, Vancouver, BC, Canada) supple-
mented with VEGF (50 ng/ml; PeproTech, Rocky Hill, NJ,
USA), SCF (100 ng/ml; PeproTech), IL-3 (20 ng/ml;
PeproTech), EGF (50 ng/ml; PeproTech), bFGF (50 ng/ml;
PeproTech), IGF-1 (50 ng/ml; PeproTech), and 30 % FBS
(Sigma). EPC colonies were manually counted under a
phase contrast microscope (Olympus) after culturing
1000 cells for 14 days. Endothelial phenotype of the
EPC colonies was confirmed by uptake of DiI-Ac-LDL
and FITC-conjugated isolectin B4 (Sigma Chemical Co.,
Milwaukee, WI, USA).
Table 1 Primer sequences for real-time quantitative PCR






Fig. 1 Culture of EPCs and modulation of Ifi204 in EPCs. a Morphology of mouse bone marrow-derived EPCs cultured at day 3 and day 7. Bar,
100 μm and 50 μm. b Uptake of DiI-Ac-LDL by EPCs. Bar, 25 μm. c Infection of Ifi204 lentivirus in EPCs. Bar, 50 μm. d Expression of Ifi204 in EPCs
after transduction of Ifi204 expressing lentivirus (n = 3). P < 0.01, LV5-Ifi204 EPCs vs LV-NC EPCs and normal EPCs. e Transfection of Ifi204 siRNA in
EPCs. Bar, 100 μm. f Expression of Ifi204 in EPCs after transfection of Ifi204 siRNA (n = 3). P < 0.001, EPCssiRNA vs normal EPCs and EPCsscramble. EPC
endothelial progenitor cell
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Hindlimb ischemia model and cell transplantation
Mice aged 8–10 weeks were anesthetized with 160 mg/kg
pentobarbital i.p. The common femoral artery, including
the superficial and other arterial branches as well as veins,
were ligated and excised to generate the hindlimb ische-
mia model as described previously [22]. EPCs were ad-
ministered intramuscularly immediately after induction of
ischemia. For the study of EPC tracking, cells were incu-
bated with our newly synthesized nanofluorogen [23], a
bolaamphiphile with a tetraphenylethene (TPE) unit at-
tached and two pyridinium salt terminated alkyl groups
(TPE-11). Cells were washed with PBS and incubated with
TPE-11 at a concentration of 16 μg/ml overnight. The
cells were then collected and 50,000 cells were
injected into the gastrocnemius muscle (two sites)
and lower ligation sites (two sites) per mouse. Laser
Doppler perfusion imaging (LDPI; Perimed Instru-
ments AB, Stockholm, Sweden) was conducted to
measure blood flow recovery ratio (ischemia/nonische-
mia). The perfusions of the ischemic and nonischemic
limbs were calculated on the basis of colored histogram
pixels, and expressed as the ratio of ischemic to nonis-
chemic hindlimb perfusion.
Detection of neovascularization in the hindlimb
ischemia model
To visualize functional vessels with blood flow, Griffonia
(Bandeiraea) Simplicifolia Lectin I (BSL I; Vector Labora-
tories, Burlingame, CA, USA) was infused into mouse
heart 15 minutes before sacrifice. Ischemic muscle samples
were embedded in OCTcompound (Sakura, Tokyo, Japan),
snap-frozen in liquid nitrogen, and cut at a thickness of
6 μm with a Leica CM 1950 Cryomicrotome (Carl Zeiss
AG, Jena, Germany). Frozen sections were incubated with
anti-BSL I antibody (Vector Laboratories) overnight at
4 °C, followed by staining with Alexa fluor 594-conjugated
anti-rabbit antibody (Invitrogen) to identify capillaries in
the ischemic tissue. Images were examined with a fluores-
cent microscope (Olympus). Cell incorporation into neo-
vascularization was detected by double-positivity of BSL I
and TPE-11.
Fig. 2 qPCR analysis of endothelial markers and growth factors in different EPC groups. mRNA expression levels of CD31 a, VE-cadherin b, vWF c,
and VEGF d in 14-day cultured cells were assessed by quantitative real-time RT-PCR. The mRNA expressions were normalized to GAPDH (n = 3).
All assays were performed in triplicate and demonstrated similar results. EPC endothelial progenitor cell
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Statistical analysis
Comparison of multiple groups was performed by ANOVA.
Two-group analysis was performed by Student t test. Values
were expressed as means ± SEM. P < 0.05 was considered
significant. Continuous variables are expressed as mean ±
SD or SEM.
Results
EPC culture and regulation of Ifi204 expression in EPCs
In the culture medium of 10 % FBS/EGM-2MV, adherent
cells changed their morphology to spindle shape after
3 days. Seven days later, most of the cells formed colonies
as reported previously (Fig. 1a). As a characteristic of
EPCs, cells could uptake Dil-Ac-LDL (Fig. 1b). We con-
structed a lentivirus vector with Ifi204 full-length CDS
cloned into the NotI/BamHI sites. EPCs were infected
with LV5-Ifi204 for 24 hours (Fig. 1c). The expression of
Ifi204 in EPCs after lentivirus transduction reached about
twofold compared with that of normal EPCs (Fig. 1d). We
also transfected Ifi204 siRNA into EPCs (Fig. 1e),
which inhibited the expression of Ifi204 by 58 ± 0.03 %
(Fig. 1f ).
Downregulation of Ifi204 inhibited EPC differentiation
We next determined the expression profiles of endothe-
lial cell-lineage markers in modified EPCs in comparison
Fig. 3 Assessment of endothelial markers in cultured EPCs by immunocytostaining and FACS. Cells were cultured and induced with Ifi204 lentivirus or
Ifi204 siRNA. Adherent cells were stained with endothelial marker CD31 a and VE-cadherin b. Bar, 50 μm. c Cell surface markers investigated by FACS
were as follows: endothelial cell (CD31 and VE-cadherin) and stem cell (CD133). Cellular surface markers were analyzed on normal EPCs (upper panel),
Ifi204 lentivirus-transduced EPCs (middle panel), and Ifi204 siRNA-transfected EPCs (lower panel). Percentages of each marker indicated in the histograms
(n = 3). EPC endothelial progenitor cell
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with normal EPCs. As shown in Fig. 2, the mRNA ex-
pression levels of CD31, VE-cadherin, vWF, and VEGF
in Ifi204 LV-transduced EPCs were at least twofold those
in Ifi204 siRNA-transfected EPCs (CD31 and VEGF in
Ifi204 LV-EPCs vs Ifi204 siRNA-EPCs, P < 0.01; VE-
cadherin and vWF in Ifi204 LV-EPCs vs Ifi204 siRNA-
EPCs, P < 0.001), and also higher than those in normal
EPCs (vWF and VEGF in Ifi204 LV-EPCs vs normal EPCs,
P < 0.01; VE-cadherin in Ifi204 LV-EPCs vs normal EPCs,
P < 0.05). Most of the Ifi204 LV-transduced EPCs expressed
CD31 (Fig. 3a) and VE-cadherin (Fig. 3b), but they were
dramatically decreased in Ifi204 siRNA-transfected EPCs.
We also analyzed the expression of endothelial cell-
lineage markers on EPCs by FACS (Fig. 3c). EPCs in-
fected with Ifi204 lentivirus had higher expression of
CD31, VE-cadherin, and CD133 than normal EPCs. In
contrast, inhibition of Ifi204 reduced the expression of
these cell surface markers in EPCs. These results demons-
trated a differentiation inhibitory effect of Ifi204 knock-
down in EPCs.
In-vitro vasculogenic activity of EPCs was modulated by
the expression of Ifi204
To determine whether Ifi204 could modulate the vascu-
logenic activity of EPCs, we carried out a tube-forming
assay on Matrigel using HUVECs and EPCs as described
previously [19–21]. As shown in Fig. 4, overexpression
of Ifi204 in EPCs significantly enhanced the numbers
of incorporated cells into tube structures of HUVECs
(P < 0.001, Ifi204 LV-EPCs: 43 ± 4 cells/HPF vs normal
EPCs: 31 ± 2 cells/HPF and Ifi204 siRNA-EPCs: 19 ± 3
cells/HPF). Inhibition of Ifi204 in EPCs, however, pro-
hibited the incorporation of EPCs into tube structures
of HUVECs. The in-vitro angiotube assay revealed that
the expression level of Ifi204 in EPCs was closely cor-
related with the angiogenesis abilities of the cells.
Colony-forming ability of EPCs was slightly enhanced by
Ifi204 siRNA transfection
Subsequently, we explored the influence of Ifi204 on
colony-formation ability, representing functional stem
Fig. 4 Tube formation assay by HUVECs incorporated with modified EPCs. DiI-labeled cells and HUVECs were seeded onto Matrigel-coated 96-well
plates in 10 % FBS/EBM2-MV without growth factors. After 24 hours in culture, incorporation of each cell population into tube-like structures formed
with HUVECs was evaluated under fluorescence microscopy. a Morphology of cultured HUVECs forming a network on Matrigel with the incorporation
of DiI-positive cells. Bar, 200 μm. b Number of incorporated DiI-positive cells into tubular structures was counted and averaged. All assays demonstrated
similar results (n = 4). EPC endothelial progenitor cell
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cell parameters. Colonies formed by EPCs could uptake
FITC isolectin B4 and DiI-Ac-LDL (Fig. 5a). In EPCs,
overexpression of Ifi204 increased the numbers of col-
onies by about twofold compared with downexpression of
Ifi204 (P < 0.05, Ifi204 LV-EPCs: 21 ± 4 vs Ifi204 siRNA-
EPCs: 11 ± 2), without reaching a significant difference
when compared with nonmodified EPCs (Fig. 5b).
Reperfusion of blood flow in ischemic hindlimb was
hindered by transplantation of Ifi204 siRNA-transfected
EPCs
To evaluate the neovascularization in response to Ifi204
modulation in EPCs, we used the hindlimb ischemia
model. The laser Doppler blood flow measurement was
performed immediately after ligation and 14 days after
surgery and cell transplantation (Fig. 6a). The blood flow
recovery ratios of ischemia to nonischemia were used as
an index of the neovascularization following hindlimb is-
chemia. Initial reductions in perfusion were similar in all
groups (Fig. 6a). Perfusion recovered incrementally over a
2-week period. Transplantation with normal EPCs and
Ifi204 LV-EPCs presented similar blood flow recovery (nor-
mal EPCs: 85 ± 0.05 % vs. Ifi204 LV-EPCs: 93 ± 0.03 %, NS)
(Fig. 6a, b). In comparison with this, transplantation with
Ifi204 siRNA-transfected EPCs had significantly less blood
flow recovery as assessed by laser Doppler (P < 0.05, Ifi204
siRNA-EPCs: 72 ± 0.02 % vs normal EPCs: 85 ± 0.05 %; P
< 0.01, Ifi204 siRNA-EPCs: 72 ± 0.02 % vs Ifi204 LV-EPCs:
93 ± 0.03 %), indicating that interference of Ifi204 expres-
sion in EPCs may prohibit their vascular reparative ability.
In-vivo vasculogenic activity of EPCs was modulated by
the expression of Ifi204
Revascularization of the ischemic hindlimb during the
14 postoperative days was additionally evaluated by im-
munohistochemistry. The capillaries in the ischemic area
are visualized by immunofluorescent staining with an anti-
body to isolectin B4, which stains endothelial cells, and
counted in representative high-power fields (HPF) (Fig. 7a).
The mice transplanted with Ifi204 overexpressing EPCs
and normal EPCs exhibited sufficient growth of neoves-
sels, while the mice transplanted with Ifi204 siRNA-
Fig. 5 Colony-forming assay by different EPC groups. a Representative staining for fluorescein isolectin B4 (ILB4) and DiI-Ac-LDL in EPC colonies. Bar,
250 μm. b Large cell colonies were counted and analyzed in each group. All assays demonstrated similar results (n = 4). EPC endothelial progenitor cell
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transfected EPCs exhibited less neoangiogenesis (P <
0.001, Ifi204 siRNA-EPCs: 13 ± 1.7/HPF vs normal EPCs:
24 ± 1.7/HPF and Ifi204 LV-EPCs: 27 ± 2.5/HPF) (Fig. 7b).
A newly-synthesized nanofluorogen, a bolaamphiphile
with a tetraphenylethene (TPE) unit attached and two pyr-
idinium salt terminated alkyl groups (TPE-11), was used
to track the implanted cells. The fluorescent spots can be
clearly seen in the cytoplasmic area of EPCs at the excita-
tion wavelength of 405 nm, and the intensity in the nuclei
region is relatively weak (Fig. 8a). In the sections of ische-
mic hindlimb, we could also detect the cells with TPE-11
labeling (Fig. 8b). EPCs with overexpression of Ifi204 in-
corporated more into vessel formation, but downexpres-
sion of Ifi204 inhibited this stimulatory effect under the
control level (Fig. 9a, b). These data indicated that the
stimulation of angiogenesis induced by EPCs in ischemic
hindlimb was related with the expression level of Ifi204.
Discussion
Interferon-inducible protein 204 (Ifi204) was shown to
be an important mediator for the differentiation of oste-
oblasts [24–26], skeletal muscle myoblasts [16, 27], and
cardiomyocytes [28, 29], previously. Ifi204 has been doc-
umented to overcame the inhibition of transcription fac-
tors such as Gata4, Nkx2.5, MyoD, and Cdfa1 by
sequestering inhibition of differentiation (Id) proteins,
thus promoting differentiation of cardiomyocytes and
osteoblasts [17]. However, the role of Ifi204 in differenti-
ation of EPCs remains unknown. Very recently, our
group reported that Ifi204 is downregulated in the bone
marrow cells of diabetes mellitus type 2 mice [18]. Be-
cause EPCs in diabetes mellitus have been reported to
be impaired in regenerative potency, we thus proposed
that Ifi204 could modulate the differentiation and regen-
erative abilities of EPCs. Our study indicates that
Fig. 6 Blood flow patterns in ischemic hindlimbs. a LDPI was used to analyze blood flow 14 days after ischemia. Top panel: representative features just
after surgery. Colors displayed correspond to intervals of perfusion value from 0 (dark) to 300 (red). Red, highest velocity; green, intermediate; blue, low;
and dark, lowest velocity. b Blood-flow ratio of ischemic-to-contralateral hindlimb after 14 days (n = 6). P < 0.05, normal EPCs vs Ifi204 siRNA-
EPCs; P < 0.01, Ifi204 LV-EPCs vs Ifi204 siRNA EPCs. EPC endothelial progenitor cell (Color figure online)
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Fig. 7 Histological analysis for capillary density in ischemic hindlimb. Cells were intramuscularly injected immediately after hindlimb ischemia.
Muscle samples were harvested following BSL I systemic perfusion 14 days after surgery. a Representative images of vessel morphology from
each treatment group. Bar, 50 μm. b Numbers of capillaries were counted in the ischemic area and averaged in each group (n = 4), respectively.
EPC endothelial progenitor cell
Fig. 8 In-vitro and in-vivo staining of EPCs by the nanofluorogen. a EPCs were incubated with TPE-11 for 12 hours. Fluorescent images of the cells
observed by a confocal microscope at the 405 nm excitations. Bar, 20 μm and 8 μm. b Sections of the ischemic gastrocnemius muscle were
observed by a confocal microscope at the 405 nm excitations. Bar, 8 μm. EPC endothelial progenitor cell
Yang et al. Stem Cell Research & Therapy  (2016) 7:111 Page 9 of 12
downregulation of Ifi204 in EPCs significantly inhibited
their endothelial differentiation and the angiogenic poten-
cies in vitro and in vivo, while upregulation of Ifi204 had
the opposite effects. To our knowledge, this is the first
study into the regulatory role of Ifi204 on the differenti-
ation and functions of EPCs.
As evidenced by RT-qPCR, immunocytochemistry, and
FACS, upregulation of Ifi204 in EPCs promoted
Fig. 9 Detection of cell incorporation into neovessels in ischemic hindlimb. Nonmodified EPCs and Ifi204 siRNA-transfected EPCs were first labeled with
TPE-11, and then were intramuscularly injected together with Ifi204 lentivirus-transduced EPCs immediately after hindlimb ischemia. Muscle samples
were harvested following BSL I systemic perfusion 14 days after surgery. a Colabeling with BSL I (red) and TPE-11 (green) appears (orange, marked by
white arrows) in the section of ischemic calf muscle. Bar, 20 μm. b Numbers of incorporated cells into vessels were counted and averaged
(n = 4). P < 0.05, normal EPCs vs Ifi204 siRNA-EPCs; P < 0.001, Ifi204 LV-EPCs vs Ifi204 siRNA EPCs. EPC endothelial progenitor cell
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endothelial differentiation of the cells and vice versa. One
of the paracrine factors of VEGF was also secreted more
in EPCs infected with Ifi204 lentivirus compared with
nonmodified and Ifi204 siRNA transfected cells,
whereas cell proliferation was not affected by Ifi204 ex-
pression levels (Additional file 1: Figure S1). The mech-
anisms for how Ifi204 affects the differentiation and
paracrine signature of EPCs were unclear and worthy of
further investigation. EPCs by themselves do not gener-
ate tubes in vitro in Matrigel [30], so researchers utilized
EPCs and HUVECs to perform the Matrigel assay [19–21].
Vascular tube formation in Matrigel is thought to recapitu-
late in-vivo vasculogenesis and angiogenesis [30]. The
more angiogenic potencies that EPCs have, the more
easily the cells could incorporate into tubular structures
of HUVECs. An in-vitro incorporation study also dem-
onstrated that the Ifi204 lentivirus-transduced EPCs
could incorporate more into the tubes of HUVECs. To
verify the effect of Ifi204, modified EPCs were trans-
planted into ischemic hindlimb. In mice with hindlimb
ischemia, downregulation of Ifi204 in EPCs impaired
endothelial differentiation, with a corresponding reduction
in neovascularization and hindlimb blood reperfusion by
postoperative day 14. The present study provided evidence
that Ifi204 is required for endothelial differentiation of
EPCs and the angiogenesis ability of EPCs was modulated
by the expression of Ifi204. These findings are consistent
with previous reports from other researchers that Ifi204
has participated in the regulation of cell differentiation.
Further studies elucidating the downstream signaling mol-
ecules of Ifi204 in the modulation of EPC differentiation
are needed.
EPCs can form colony-forming units (CFU) in methyl-
cellulose supplied with growth factors. The colony-forming
assay determines the stemness of EPCs, and colonies are
classified into two types according to their morphology:
primitive (small cell) colonies and definitive (large cell) col-
onies [19, 31]. The primitive CFU is a predominantly pro-
liferative population of cells and the definitive CFU is a
predominantly vasculogenic population with greater adhe-
sion, migration, differentiation, and tabularization poten-
tial. EPCs downexpressing Ifi204 formed less large cell
colonies than those overexpressing Ifi204, which indicates
that Ifi204 inhibition may block the stemness and vasculo-
genic potency of EPCs and supports all of our findings.
TPE-11 is a nanofluorogen newly synthesized by our
group. We have already used it in the labeling of Hela
cells, and the biocompatibility of the nanofluorogens
formed by TPE-11 was quite good in cells [23]. TPE-11
can be transported and passaged to the progeny cells by
microtubules (unpublished observations). We also found
that TPE-11 can be retained stably in the embryoid of
the embryonic stem cells (unpublished observations:
Shixin Zhou (S. Z.), Yijun Xia (Y. X.), Yinan Liu (Y. L.),
Qihua He (Q. H.) and Bo Song (B. S.). 2016.). As far as
we are aware, this work represents the first experimental
demonstration of in-vivo cell labeling using this emer-
ging luminescent system.
Conclusions
This study makes two contributions to EPC-mediated ther-
apy of hindlimb ischemia. First, Ifi204 is required for EPC
differentiation and neovascularization in vitro and in vivo.
Second, EPCs labeled with TPE-11 could be detected in the
ischemic hindlimb. The regulatory roles of Ifi204 in EPC
differentiation need to be elucidated further and may bene-
fit the therapeutic strategies for ischemic vascular diseases.
Additional file
Additional file 1: Figure S1. Showing the detection of cell proliferation
by CCK-8 assay. A Cells were transfected with Ifi204 siRNA and control
siRNA. OD values were read after 2 hours of incubation with CCK-8 solution.
B Cells were infected with Ifi204 LV5 and control LV5. OD values were read
after 2 hours of incubation with CCK-8 solution. (JPG 41 kb)
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